Page 1 of Clinical Trials for ( Drug Neoadjuvant gemcitabine AND capecitabine AND and docetaxel ), 5 Total Matches
- 1RecruitingLast Updated: October 27, 2011Condition(s): Pancreatic Cancer Stage II; Pancreatic Cancer Stage III
- 2Active, not recruitingLast Updated: January 28, 2012Condition(s): Breast Cancer
- 3TerminatedLast Updated: May 26, 2011Condition(s): Pancreatic Neoplasms
- 4RecruitingLast Updated: October 28, 2011Condition(s): Pancreatic Cancer Stage IVA
- 5RecruitingLast Updated: April 30, 2012Condition(s): Adenocarcinoma of the Pancreas; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Neoadjuvant+gemcitabine%2C+capecitabine%2C+and+docetaxel
